DUBLIN, Sept. 26, 2019 /PRNewswire/ -- Alkermes plc
(Nasdaq: ALKS) announced today that management will participate in
a fireside chat at the Cantor Fitzgerald Global Healthcare
Conference on Thursday, Oct. 3, 2019
at 7:45 a.m. ET (12:45 p.m. BST) from New York. The audio portion of the fireside
chat may be accessed under the Investors tab on
www.alkermes.com and will be archived for 14 days.
Alkermes plc is a fully integrated, global
biopharmaceutical company developing innovative medicines for the
treatment of central nervous system (CNS) diseases and oncology.
The company has a diversified commercial product portfolio and a
substantial clinical pipeline of product candidates for chronic
diseases that include schizophrenia, depression, addiction,
multiple sclerosis and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D
center in Waltham, Massachusetts;
a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in
Wilmington, Ohio. For more
information, please visit Alkermes' website
at www.alkermes.com.
Contact:
Alex Braun
Investor Relations
+1 781 296 8493
Logo -
https://mma.prnewswire.com/media/616416/Alkermes_plc_Logo.jpg